Adjuvant radiotherapy in women with stage I endometrial cancer: A systematic review

Gynecologic Oncology

Volumn 102, Issue 2, 2006, Pages 361-368

  Lukka, Himu ^a   Chambers, Alexandra ^b   Fyles, Anthony ^c   Thephamongkhol, Kullathorn ^a   Fung Kee Fung, Michael ^d   Elit, Laurie ^a   Kwon, Janice ^e  

^a Juravinski Regional Cancer Centre   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d OTTAWA REGIONAL CANCER CENTRE   (Canada)

^e LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Adjuvant radiotherapy; Endometrial carcinoma; Pelvic control; Risk of recurrence; Stage I

Indexed keywords

CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COCHRANE LIBRARY; DATA BASE; EMBASE; ENDOMETRIUM CANCER; EXTERNAL BEAM RADIOTHERAPY; HIGH RISK PATIENT; HUMAN; MEDICAL LITERATURE; MEDLINE; OUTCOME ASSESSMENT; PELVIS; PRIORITY JOURNAL; RADIATION HAZARD; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; TIME SERIES ANALYSIS;

ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS;

EID: 33745915000     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.03.008     Document Type: Review

References (16)

1. National Cancer Institute: Endometrial Cancer. National Cancer Institute. Available at: http://www.nci.nih.gov/cancertopics/pdq/treatment/endometrial/healthprofessional.
2. DiSaia P.J., Creasman W.T., Boronow R.C., et al. Risk factors and recurrent patterns in stage I endometrial cancer. Am. J. Obstet. Gynecol. 151 8 (1985) 1009-1015
3. Shumsky A.G., Brasher P.M., Stuart G.C., et al. Risk-specific follow-up for endometrial carcinoma patients. Gynecol. Oncol. 65 3 (1997) 379-382
4. Rogerson L., and Downes E. How do UK gynaecologists manage endometrial carcinoma? A national survey. Eur. J. Gynaecol. Oncol. 19 4 (1998) 331-332
5. Einhorn N. Uterine cancer. Acta Oncol. 35 Suppl. 7 (1996) 81-85
6. NHS. Centre for reviews and dissemination: management of gynaecological cancers. Eff. Health Care 5 (1999) 1-12
7. Look K. Stage I-II endometrial adenocarcinoma evolution of therapeutic paradigms: the role of surgery and adjuvant radiation. Int. J. Gynecol. Cancer 12 (2002) 237-249
8. Einhorn N., Trope C., Ridderheim M., et al. A systematic overview of radiation therapy effects in uterine cancer (corpus uteri). Acta Oncol. 42 (2003) 557-561
9. Keys H.M., Roberts J.A., Brunetto V.L., et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate-risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol. Oncol. 92 3 (2004) 744-751
10. Creutzberg C.L., van Putten W.L., Koper P.C., et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 355 9213 (2000) 1404-1411
11. Piver M.S., Yazigi R., Blumenson L., et al. A prospective trial comparing hysterectomy, hyspterectomy plus vaginal radium, and uterine radium plus hysterectomy in stage I endometrial carcinoma. Obstet. Gynecol. 54 (1979) 85-89
12. Aalders J., Abeler V., Kolstad P., et al. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma. Obstet. Gynecol. 56 (1980) 419-426
13. Garzetti G.G., Ciavattini A., Muzzioli M., et al. The relationship of clinical-pathological status and adjuvant treatment with natural killer cell activity in stage I and II endometrial carcinoma. Acta Obstet. Gynecol. Scand. 73 (1994) 652-657
14. Graham J. The value of preoperative of postoperative treatment by radium for carcinoma of the uterine body. Surg. Gynecol. Obstet. 132 (1971) 855-860
15. Creutzberg C.L., van Putten W.L.J., Koper P.C., et al. Survival after relapse in patients with endometrial cancer: results from a randomized trial. Gynecol. Oncol. 89 (2003) 201-209
16. Scholten A.N., van Putten W.L., Beerman H., Smit V.T., Koper P.C., Lybeert M.L., et al. Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review. Int. J. Radiat. Oncol. Biol. Phys. 63 3 (2005 (Nov 1)) 834-838 (electronic publication 2005 May 31)